BioScrip To Host Fourth Quarter and Full-Year 2016 Results Call
February 15 2017 - 11:00AM
BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will
release its fourth quarter and full-year 2016 financial results on
Friday, March 3, 2017, before the opening of the U.S. financial
markets.
Daniel E. Greenleaf, President and Chief Executive Officer, and
Jeffrey M. Kreger, Senior Vice President, Chief Financial Officer
and Treasurer, will conduct a conference call as follows:
Date |
|
Friday, March 3, 2017 |
Time |
|
9:00 a.m. EST |
Toll free
(U.S.) |
|
(888) 372-9592 |
Webcast
(live and replay) |
|
www.bioscrip.com |
|
|
|
A replay of the conference call will be available for one week
after the call's completion by dialing (855) 859-2056 (US) and
entering conference call ID number 5266355.
About BioScrip, Inc.BioScrip, Inc. is a leading
national provider of infusion and home healthcare management
solutions. BioScrip partners with healthcare providers, including
physicians, hospital systems, skilled nursing facilities, and with
healthcare payors to provide patients better access to high
quality, efficient post-acute care services. BioScrip operates with
a commitment to bring infusion therapy services into the home or
alternate-site settings. By collaborating with the full spectrum of
healthcare professionals and the patient, BioScrip provides
cost-effective care that is driven by clinical excellence, customer
service, and values that promote positive outcomes and an enhanced
quality of life for those it serves.
Investor Contacts:
Jeffrey M. Kreger
Chief Financial Officer
T: (720) 697-5200
jeffrey.kreger@bioscrip.com
David Clair
ICR, Inc.
T: (646) 277-1266
david.clair@icrinc.com
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Sep 2023 to Sep 2024